![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (834kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-593212
- DOI to cite this document:
- 10.5283/epub.59321
This publication is part of the DEAL contract with Springer.
Abstract
Background Decreases in symptom load and improvements in quality of life are important goals in the invasive treatment of symptomatic chronic coronary syndrome (CCS). To date, it is not known which patients profit most from the invasive treatment. Methods This sub-analysis of the prospective, multi-centre PLA-pCi-EBO trial includes 145 patients with symptomatic CCS and successful PCI. The ...

Owner only: item control page